Page 668 - Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice
P. 668

Fluid Therapy with Macromolecular Plasma Volume Expanders  655


            CLINICAL USES                                       comparing dextran/hypertonic saline with isotonic saline
            Support Of Intravascular Volume                     for fluid resuscitation of dogs suffering from gastric dila-
                                                                tation-volvulus syndrome 137  and trauma 138  did not
            The principle use of colloids is for intravascular volume
                                                                reveal a consistent benefit with either approach.
            expansion in patients with hypovolemic or distributive
            shock. Colloids are generally considered to be more effec-  Recommended Dose
            tive for this purpose on a mL/kg basis than isotonic
            crystalloids. However, given the many factors involved  The recommended dosage for the high molecular weight
            in the efficacy and persistence of colloid therapy and  hydroxyethyl starches, the gelatins, and the dextrans is
            the heterogeneous nature of the patient population in  20 mL/kg/day. Dependent on the patient’s status, this
            which they are used, it is crucial to carefully assess the  may be administered as one or more boluses with the
            need for colloidal therapy and the clinical response of  speed of bolus administration being dependent on the
            the patient. Colloid therapy is not a panacea; rather it  clinical status of the patient. Although higher dosages
                                                                                                           106,150
            represents one more group of drugs with specific    have been used without apparent adverse effects,
            indications, contraindications, benefits, and risks. The  deleterious effects on coagulation (see later discussion)
            treatment of critically ill human patients with colloid  occur more commonly at and above this dosage. The
            solutions recently has been questioned in several meta-  newer low molecular weight hydroxyethyl starches avail-
            analyses of randomized clinical trials in human patients.  able in Europe may be used at higher doses of up to
            17,35,116,139,171                                   50 mL/kg/day. 89  A dosage of 20 mL/kg represents
                         Despite the limitations of randomized
            clinical trials and meta-analyses, 128  all showed a trend  one quarter of a dog’s blood volume, and if repeated
            toward increased mortality when colloids were used to  doses are required to maintain perfusion, the underlying
            resuscitate human trauma patients. Subdivision of the  reason should be pursued aggressively. Cats seem to be
            patients in one study 171  demonstrated that in trauma  much more likely to develop volume overload than dogs,
            patients there was a 12.3% difference in mortality rate  at least in part due to their smaller blood volume as a per-
            in favor of crystalloid therapy, and when data from studies  centage of body weight. The suggested dose in cats is
            that used nontrauma patients were pooled, there was a  5 mL/kg. Lastly, colloid solutions may not contain a bac-
            7.8% difference in mortality rate in favor of colloid treat-  teriostat and such formulations are therefore intended for
            ment. The authors concluded:                        single-dose usage.

              “in patients with trauma who are septic and in whom the  COLLOID THERAPY IN
              capillary leak syndrome leads to adult respiratory distress  PULMONARY DISEASE
              syndrome, it may be assumed that colloid resuscitation
              would be no better than crystalloid resuscitation.  Many pulmonary diseases result in accumulation of excess
              In this study the meta-analysis of published data showed  fluid in the interstitium alone or in the interstitium and
              that this form of treatment is deleterious. In patients who
              are nonseptic or having elective surgery, however, the  alveoli. This increase in so-called extravascular lung
                                                                water is synonymous with pulmonary edema. The lung
              basement membrane is intact, and meta-analysis of data
              in this setting showed that treatment with colloids would  is relatively resistant to the edemagenic effects of
              be efficacious.”                                  hypoproteinemia, 182  and the two most important
                                                                mechanisms by which pulmonary edema occurs are an
              The likely explanation of these results is that if vascular  increase in pulmonary hydrostatic pressure and an increase
            leak is sufficiently severe to allow significant colloid  in pulmonary microvascular permeability. 153  High-pres-
            extravasation then colloids may worsen outcome com-  sure edema may occur secondary to left-sided heart failure
            pared with crystalloids. A meta-analysis that was designed  or volume overload, whereas increased permeability
            a priori to investigate resuscitation after trauma showed a  edema may be caused by conditions such as pneumonia,
            lower mortality rate associated with the use of crystalloid  toxic lung injury, and systemic inflammatory response
            fluids. 35                                          syndrome. In some clinical settings, the pathogenesis of
              Similar large scale studies do not yet exist within the  pulmonary edema may be unclear or include both
            veterinary field. In experimental dogs given standard  components (e.g., neurogenic and reexpansion edema).
            boluses of isotonic saline (80 mL/kg) or hetastarch    The pulmonary endothelium is relatively permeable to
                                                                                                          170
            (20 mL/kg), volume expansion was initially significantly  protein compared with other tissues, and albumin  and
                                                                    86
            greater with isotonic saline, was not significantly different  HES  equilibrate more rapidly with the interstitial space
            30 minutes following administration, and was greater,  even in a normal lung. Consequently, the effective COP
            although not significantly so, in the hetastarch group  gradient that can be generated between the intravascular
                       147
            after 4 hours.  Hetastarch was more effective than crys-  space and the pulmonary interstitium is lower than in
            talloid in reversing isoflurane-induced hypotension in  other tissues. Therefore the lung must rely more on
                                     1
            healthy experimental beagles. Two small clinical studies  increased lymph flow than interstitial COP dilution to
   663   664   665   666   667   668   669   670   671   672   673